Document is current
Any future updates will be listed below
-
Authors
Miyanishi, Mao
Yaguramaki, Toru
Maehara, Yasuhiro
Nagata, Osamu
- License Information
-
More Information
Article History
Received: 13 July 2021
Revised: 4 November 2021
Accepted: 8 November 2021
First Online: 11 January 2022
Declarations
:
: Not applicable.
: Written informed consent was obtained from the patient.
: ON has received lecture fees from Mundipharma K.K. that manufactures and sells remimazolam. The other authors declare that they have no competing interests.
